Press Releases about Arrowhead Pharmaceuticals, Inc. - Common Stock![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Arrowhead Presents New Clinical Data on ARO-HIF2 at ASCO GU 2022
February 17, 2022
Via Business Wire
![]()
Arrowhead Pharmaceuticals Reports Fiscal 2022 First Quarter Results
February 02, 2022
Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]() ![]()
Arrowhead Pharmaceuticals Reports Fiscal 2021 Year End Results
November 22, 2021
Via Business Wire
![]() ![]()
Arrowhead Announces JNJ-75220795 in Development for NASH
November 17, 2021
Via Business Wire
![]() ![]()
Arrowhead Presents New Clinical Data on ARO-APOC3 at AHA 2021
November 15, 2021
Via Business Wire
![]() ![]() ![]()
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Year End Results
November 01, 2021
Via Business Wire
![]() ![]() ![]() ![]() ![]() Via Business Wire
![]()
Arrowhead Earns $10 Million Phase 1 Milestone Payment
September 28, 2021
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|